InnoCare Pharma is a biopharmaceutical company based in Beijing that discovers and develops medicines for cancer and autoimmune diseases. Its main commercial product is orelabrutinib, a small-molecule drug used to treat certain lymphomas and other blood cancers, and the company also runs clinical programmes in autoimmune conditions. Its customers are hospitals, physicians and patients in China, and it works with partners to develop and commercialise its therapies in other markets.
The shares are listed on the Hong Kong Stock Exchange in Hong Kong under the code 9969, and the price on this page is in Hong Kong dollars (HKD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Fair price profile
Ranks #590 of 2611 on the Hong Kong Stock Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Hong Kong yet.
TrendStrong
74/100
Trading above its long-term averages and near its highs.
See the numbers →
Above 200-day average-4.8%
From 52-week high-21.0%
MomentumWeak
43/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-13.7%
6-month return-20.5%
12-month, skipping last month-9.2%
Stability (higher is calmer)Fair
65/100
Typical risk for this exchange.
See the numbers →
Volatility, 1 year (lower is calmer)49.9%
Worst drawdown, 1 year (smaller is calmer)-36.7%
LiquidityStrong
92/100
Trades actively.
See the numbers →
Avg daily value traded116.32M HKD
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Hong Kong when fundamentals data for this market is added. All Hong Kong stocks.
52-wk range 9.65 – 16.75Daily closes, split-adjusted
Signals
50-day average14.25
200-day average13.13
Golden/death cross (60d)Golden, 41 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.77
Technical summary
Daily
Strongly bearish
2 bullish · 2 neutral · 12 bearish
Weekly
Bearish
3 bullish · 1 neutral · 8 bearish
Monthly
Bearish
2 bullish · 1 neutral · 5 bearish
Moving averages (daily)
SMA 10
12.68
Bearish
EMA 10
12.72
Bearish
SMA 20
13.64
Bearish
EMA 20
13.28
Bearish
SMA 50
14.25
Bearish
EMA 50
13.76
Bearish
SMA 100
13.37
Bearish
EMA 100
13.68
Bearish
SMA 200
13.13
Bearish
EMA 200
13.45
Bearish
Oscillators (daily)
RSI (14)
39.91
Neutral
MACD (12, 26)
-0.62
Bearish
Momentum (12)
-15.48
Bearish
Stochastic %K (14)
19.14
Bullish
Williams %R (14)
-80.86
Bullish
CCI (20)
-76.10
Neutral
Pivot points (classic, last session)
S3
11.49
S2
11.83
S1
12.17
Pivot
12.51
R1
12.85
R2
13.19
R3
13.53
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in HKD. Educational only, not financial advice.
